Top Page
Trulieve Cannabis
(OTC:TRUL)
Trulieve Cannabis (TRUL) vs. iShares MSCI Canada ETF (EWC)
Trulieve Cannabis Business Overview & Revenue Model
Trulieve Cannabis Earnings Call Summary
Trulieve Cannabis Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.19B | 1.19B | 1.13B | 1.24B | 938.38M | 521.53M |
| Gross Profit | 726.44M | 715.75M | 588.63M | 682.00M | 566.13M | 386.42M |
| EBITDA | 274.49M | 282.80M | -21.98M | 239.75M | 283.59M | 207.87M |
| Net Income | -166.65M | -155.10M | -526.80M | -205.10M | 18.03M | 63.00M |
Balance Sheet | ||||||
| Total Assets | 2.92B | 2.87B | 2.73B | 3.40B | 3.41B | 816.11M |
| Cash, Cash Equivalents and Short-Term Investments | 392.58M | 299.20M | 201.37M | 212.30M | 230.65M | 146.71M |
| Total Debt | 823.70M | 824.46M | 792.57M | 1.03B | 859.02M | 168.60M |
| Total Liabilities | 1.71B | 1.62B | 1.32B | 1.47B | 1.26B | 368.21M |
| Stockholders Equity | 1.23B | 1.26B | 1.41B | 1.93B | 2.15B | 447.90M |
Cash Flow | ||||||
| Free Cash Flow | 60.28M | 116.82M | 146.35M | -161.49M | -293.22M | -47.10M |
| Operating Cash Flow | 197.84M | 271.48M | 201.84M | 23.10M | 12.90M | 99.64M |
| Investing Cash Flow | -119.90M | -206.62M | -37.47M | -215.06M | -215.18M | -174.65M |
| Financing Cash Flow | -33.05M | -33.44M | -175.59M | 177.80M | 289.23M | 129.91M |
Trulieve Cannabis Technical Analysis
Trulieve Cannabis Risk Analysis
Trulieve Cannabis Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | C$865.85M | 160.70 | -10.92% | 3.77% | -0.94% | -540.90% | |
65 Neutral | C$1.33B | 51.18 | 3.34% | ― | 22.20% | ― | |
64 Neutral | $2.22B | 54.06 | 2.42% | ― | 6.18% | -28.69% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | C$3.07B | ― | -27.61% | ― | -3.38% | -31.35% | |
48 Neutral | C$1.78B | ― | -9.95% | ― | 4.27% | 3.41% | |
48 Neutral | $692.98M | ― | -14.33% | ― | -6.48% | 47.36% |
Trulieve Cannabis Corporate Events
Trulieve Cannabis Corp. reported its third-quarter 2025 financial results, highlighting a revenue of $288 million with a 59% gross margin. Despite a net loss of $27 million, the company achieved an adjusted EBITDA of $103 million, demonstrating operational discipline and strong cash flow. The company also expanded its product offerings and distribution, launched a new mobile app, and announced plans to redeem $368 million of senior secured notes due in 2026.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$9.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
On November 4, 2025, Trulieve Cannabis Corp. announced a notice of redemption for its outstanding 8% senior secured notes due 2026, totaling US$368 million. The redemption, set for December 5, 2025, will be executed at 100% of the principal plus accrued interest, leading to the delisting of the notes from the Canadian Securities Exchange, potentially impacting the company’s financial strategy and market positioning.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. announced it will hold a conference call on November 5, 2025, to discuss its third quarter financial results. The call will be led by CEO Kim Rivers and CFO Jan Reese, and is expected to provide insights into the company’s financial performance and operational strategies, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. has introduced five new flavors in its Onward and Upward THC-infused beverage line, reflecting the rising demand for THC beverages. These new flavors, crafted in the USA and infused with naturally derived THC and CBD, are available online and at retail locations in Florida and Illinois, enhancing consumer choice and potentially strengthening Trulieve’s market position in the cannabis beverage sector.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. announced the opening of a new dispensary in Bisbee, Arizona, expanding its presence in the state and enhancing access for patients and customers in south Cochise County. The new location will offer a wide range of Trulieve’s in-house brands and partner products, reinforcing the company’s commitment to providing affordable, high-quality cannabis products and an elevated customer experience.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. has been honored with seven awards at the 2025 Brandon Hall Group HCM Excellence Awards for its innovative employee development programs. These accolades highlight Trulieve’s commitment to excellence in employee training and talent management, with programs like TruU ATTAIN, Seeds to Success, and SPHERE of Influence receiving recognition for their effective approaches to skill development, learning, and employee recognition.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. has announced the appointment of Matthew Foulston to its Board of Directors and Jan Reese as Chief Financial Officer. These strategic appointments are expected to bring valuable experience and insight to Trulieve as it navigates the evolving cannabis landscape, aiming to enhance shareholder value and capitalize on growth opportunities.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. has announced the opening of a new dispensary in Cincinnati, Ohio, operated by Harvest Grows LLC under a licensing agreement. This expansion marks a significant step in Trulieve’s growth strategy, enhancing its presence in Ohio and offering a wide range of cannabis products to both adult-use customers and medical patients. The new location will provide various services, including walk-in, express pickup, and drive-through options, contributing to Trulieve’s goal of delivering high-quality products and customer experiences.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. announced its participation in the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, where its Vice President of Investor Relations, Christine Hersey, will engage in a fireside chat and investor meetings. This event participation underscores Trulieve’s commitment to engaging with investors and stakeholders, potentially impacting its industry positioning and growth trajectory.
The most recent analyst rating on (TSE:TRUL) stock is a Buy with a C$21.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Trulieve Cannabis Corp. is a leading U.S.-based cannabis company known for its vertically integrated operations and significant market presence in states like Arizona, Florida, and Pennsylvania. The company focuses on providing high-quality cannabis products and expanding its retail and distribution networks.
Trulieve Cannabis (OTC) recently held its earnings call, revealing a mixed sentiment. The company showcased a strong second quarter with notable improvements in gross margin and EBITDA, alongside substantial cash reserves and successful branded product growth. However, challenges such as pricing compression, a projected revenue decline, and a reported net loss due to tax expenses were also highlighted. Trulieve remains focused on federal reform and market expansion.
Trulieve Cannabis Corp. reported its second quarter 2025 financial results, highlighting a revenue of $302 million and a gross margin of 61%. Despite a net loss of $14 million, the company achieved an adjusted EBITDA of $111 million and expanded its retail presence with new dispensaries in Florida and Ohio. The company also launched new products and supported social initiatives, positioning itself as a leader in the cannabis industry with strong operational metrics and a focus on growth and reform.
The most recent analyst rating on (TSE:TRUL) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.